Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

197.96
-2.3700-1.18%
Post-market: 197.960.00000.00%19:23 EST
Volume:142.81K
Turnover:28.56M
Market Cap:3.90B
PE:79.49
High:202.97
Open:200.89
Low:197.33
Close:200.33
52wk High:212.49
52wk Low:93.58
Shares:19.68M
Float Shares:19.16M
Volume Ratio:0.49
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.49
EPS(LYR):-0.2204
ROE:5.42%
ROA:1.48%
PB:4.10
PE(LYR):-897.99

Loading ...

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Ligand Pharma (LGND)

TIPRANKS
·
Sep 25

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292

GlobeNewswire
·
Sep 25

Arecor Therapeutics: Royalty Financing Agreement With Ligand Pharmaceuticals Incorporated Which Will Raise Non-Dilutive Capital of up to $11 Mln

THOMSON REUTERS
·
Sep 25

Ligand Pharmaceuticals Director Jason Aryeh Reports Disposal of Common Shares

Reuters
·
Sep 25

Ligand Pharmaceuticals Inc - Maturity Date Extended to September 12, 2028 - SEC Filing

THOMSON REUTERS
·
Sep 17

Craig-Hallum Sticks to Its Buy Rating for Ligand Pharma (LGND)

TIPRANKS
·
Sep 12

John W. Kozarich, Director, Reports Disposal of Common Shares of Ligand Pharmaceuticals Inc

Reuters
·
Sep 05

Ligand Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Sep 03

Oppenheimer Adjusts Price Target on Ligand Pharmaceuticals to $190 From $167, Maintains Outperform Rating

MT Newswires Live
·
Sep 03

Ligand Pharmaceuticals, Inc. : Oppenheimer Raises Target Price to $190 From $167

THOMSON REUTERS
·
Sep 03

Ligand Pharmaceuticals Is Maintained at Buy by Benchmark

Dow Jones
·
Sep 02

Ligand Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 29

Ligand Pharmaceuticals Inc. Unveils Corporate Presentation Highlighting Biopharma Royalty Investment Strategies and Financial Performance

Reuters
·
Aug 28

BUZZ-OmniAb drops after $30 mln equity financing

Reuters
·
Aug 25

Ligand Pharmaceuticals Announces $400 Million Convertible Senior Notes Offering

Reuters
·
Aug 15

Ligand Announces Closing of Convertible Senior Notes Offering

THOMSON REUTERS
·
Aug 15

BUZZ-U.S. STOCKS ON THE MOVE-Starbucks, Resideo Technologies, Mercury Systems

Reuters
·
Aug 12

Stock Track | Ligand Pharmaceuticals Soars 5.29% After Pricing $400 Million Convertible Notes Offering

Stock Track
·
Aug 12

Stock Track | Ligand Pharmaceuticals Soars 5.29% Following $400 Million Convertible Notes Offering

Stock Track
·
Aug 12

BRIEF-Ligand Prices $400 Million Convertible Senior Notes Offering

Reuters
·
Aug 12